Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells
Open Access
- 11 May 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5), e0250889
- https://doi.org/10.1371/journal.pone.0250889
Abstract
The ezrin/radixin/moesin (ERM) family proteins act as linkers between the actin cytoskeleton and P-glycoprotein (P-gp) and regulate the plasma membrane localization and functionality of the latter in various cancer cells. Notably, P-gp overexpression in the plasma membrane of cancer cells is a principal factor responsible for multidrug resistance and drug-induced mutagenesis. However, it remains unknown whether the ERM proteins contribute to the plasma membrane localization and transport function of P-gp in human colorectal cancer cells in which the subcellular localization of ERM has yet to be determined. This study aimed to determine the gene expression patterns and subcellular localization of ERM and P-gp and investigate the role of ERM proteins in the plasma membrane localization and transport function of P-gp using the human colon adenocarcinoma cell line LS180. Using real-time reverse transcription polymerase chain reaction and immunofluorescence analyses, we showed higher levels of ezrin and moesin mRNAs than those of radixin mRNA in these cells and preferential distribution of all three ERM proteins on the plasma membrane. The ERM proteins were highly colocalized with P-gp. Additionally, we show that the knockdown of ezrin, but not of radixin and moesin, by RNA interference significantly decreased the cell surface expression of P-gp in LS180 cells without affecting the mRNA expression of P-gp. Furthermore, gene silencing of ezrin substantially increased the intracellular accumulation of rhodamine123, a typical P-gp substrate, with no alterations in the plasma membrane permeability of Evans blue, a passive transport marker. In conclusion, ezrin may primarily regulate the cell surface localization and transport function of P-gp as a scaffold protein without influencing the transcriptional activity of P-gp in LS180 cells. These findings should be relevant for treating colorectal cancer, which is the second leading cause of cancer-related deaths in males and females combined.This publication has 77 references indexed in Scilit:
- Viability Reagent, PrestoBlue, in Comparison with Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial AssaysInternational Journal of Microbiology, 2013
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistanceDrug Resistance Updates, 2012
- Intracellular trafficking of P-glycoproteinThe International Journal of Biochemistry & Cell Biology, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- The Actin-Cytoskeleton Pathway and Its Potential Role in Inflammatory Bowel Disease-Associated Human Colorectal CancerGenetic Testing and Molecular Biomarkers, 2010
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous MetastasesCancer Research, 2009
- Pleiotropic function of ezrin in human metastatic melanomasInternational Journal of Cancer, 2009
- Effects of budesonide on P‐glycoprotein expression in intestinal cell linesBritish Journal of Pharmacology, 2007
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Dynamic and intracellular trafficking of P‐glycoprotein‐EGFP fusion protein: Implications in multidrug resistance in cancerInternational Journal of Cancer, 2004